IND approval

SHANGHAI and HONG KONG, China, June 10, 2026 Antengene announced that China’s National Medical Products Administration (NMPA) has approved...

WASHINGTON, D.C., April 24, 2026 The U.S. Food and Drug Administration has announced a series of accelerated regulatory actions...

Alpharetta, Georgia, U.S. | April 15, 2026 Dogwood Therapeutics has announced a major regulatory milestone with the U.S. Food...